Adagio Medical (ADGM) Director James L. Cox Receives 30,000-Share Option Award

What Happened
James L. Cox, a director of Adagio Medical Holdings, Inc. (ADGM), received a grant of a derivative equity award on 2026-06-16: an option covering 30,000 shares reported at $0.00 on the Form 4 (transaction code A). This award is an annual stock option granted under the company's Non-Employee Director Compensation Policy and the 2024 Equity Incentive Plan. The option vests in equal monthly installments over one year (1/12th, or 2,500 shares, vest at the end of each month of continuous service beginning 06/16/2026). The Form 4 reports the grant value as $0 because it is a derivative/option award; it does not reflect any immediate cash purchase of shares.

Key Details

• Transaction date: 2026-06-16; reported acquisition price on Form 4: $0.00; transaction type: A (award/grant).
• Vesting: 30,000 options vest 1/12th monthly over one year (starting 06/16/2026) — 2,500 options vest each month with continued service.
• Shares owned after transaction: not disclosed in the provided filing excerpt.
• Footnote: Award granted under the Issuer’s Non‑Employee Director Compensation Policy and 2024 Equity Incentive Plan; described as the annual director stock option.
• Filing timeliness: Form 4 was filed 2026-08-12, 57 days after the transaction (appears late relative to the usual Form 4 reporting deadline), which may reduce short-term transparency.

Context: This is a derivative option grant (not an immediate purchase of shares). Director option awards are commonly used as routine compensation for non-employee board members; they give the right to acquire shares as they vest and typically require exercise to convert to stock (strike/exercise price not specified in the provided excerpt). This transaction does not in itself indicate a sale or direct purchase of shares.